Attached files
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002
In
connection with the Annual Report on Form 10-K of MEDITE Cancer
Diagnostics, Inc. (the “Company”) for the fiscal year
ended December 31, 2017 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I,
Stephen Von Rump, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:
1.
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
2.
The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
Date:
May 17, 2018
|
|
|
|
|
/s/ Stephen Von
Rump
|
|
|
|
Stephen Von
Rump
Chief Financial
Officer
|
|
(Principal
Financial Officer)
|